Sign in

CIK 0001850119 · <br>Emerging growth company

Century Therapeutics, Inc.

Sign in to watch
Ticker
IPSC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
842040295
Phone
215-981-4000
Business address
25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Grant or award SVP Finance & Operations acquired 17,007 shares (grant or award)
  4. 4 Planned sale See Remarks sold 5,000 shares at $3.00 ($14,989)
  5. 4 Planned sale See Remarks sold 5,000 shares at $3.00 ($14,978)
  6. 4 Planned sale See Remarks sold 5,000 shares at $3.12 ($15,619)
  7. 4 Open-market sale SVP Finance & Operations sold 257 shares at $3.11 ($798)
  8. 4 Open-market sale Chief Operations Officer sold 913 shares at $3.11 ($2,836)
  9. 4 Planned sale See Remarks sold 5,000 shares at $3.10 ($15,490)
  10. 4 Grant or award President and CEO acquired 17,425 shares (grant or award)
  11. 4 Grant or award SVP Finance & Operations acquired 14,000 shares (grant or award)
  12. 4 Grant or award See Remarks acquired 24,000 shares (grant or award)
  13. 4 Grant or award Chief Operations Officer acquired 24,000 shares (grant or award)
  14. 4 Grant or award President of R&D acquired 24,000 shares (grant or award)
  15. 4 Open-market sale Chief Operations Officer sold 53,515 shares at an average $5.04 ($269,682)
  16. 4 Open-market sale Chief Operations Officer sold 485 shares at $4.86 ($2,358)
  17. 4 Open-market sale SVP Finance & Operations sold 1,200 shares at an average $4.14 ($4,969)
  18. 4 Open-market sale Chief Operations Officer sold 3,819 shares at an average $4.14 ($15,821)
  19. 4 Grant or award President and CEO acquired 1,453,279 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 6 of 10 · 188 filings